OpenAI Stock: Can You Buy It Today? 6 Ways In at $852B

OpenAI has no public ticker and no listing date, but its $852 billion private valuation is tradable today through Forge, EquityZen, Hiive, tender offers, and closed-end funds like RVI. That's the short answer. The longer answer is more interesting.

Google "OpenAI stock" and you'll find a fake ticker (OPAI.PVT on Yahoo Finance is a private-market tracker, not a real symbol) sitting next to a genuine secondary market where accredited investors already trade shares. We track the entity's private pricing on our AI valuations dashboard, and the August 2026 data shows a company that just proved its $852 billion price tag is real money changing hands, not a paper mark.

Can You Buy OpenAI Stock Today?

You cannot buy OpenAI stock on a public exchange because the company has not completed an IPO — it confidentially filed a draft S-1 with the SEC on June 8, 2026, but has not set a listing date and has said timing "may be a while." What you can buy is exposure to the same $852 billion valuation through private secondary markets, which require SEC accredited-investor status and are subject to OpenAI's own transfer restrictions and right of first refusal.

That distinction matters because pricing on those secondary markets doesn't always match the headline valuation. Forge Global quoted OpenAI shares near $721.85 in mid-August 2026, a discount to the per-share price implied by the $852 billion Series H mark — a gap that reflects illiquidity, transfer friction, and the fact that secondary sellers sometimes need cash faster than buyers are willing to pay a premium for.

Six Ways to Get OpenAI Stock Exposure Before the IPO

There isn't one "buy OpenAI stock" button — there are six distinct routes, each with different minimums, fees, and eligibility requirements. Forge Global runs an order-matching marketplace where accredited investors trade existing shareholders' stakes directly, with OpenAI shares quoted around $721.85 in mid-August 2026. EquityZen pools smaller checks into SPVs that acquire shares once a deal clears OpenAI's right of first refusal, with a $5,000 minimum ($10,000 for enhanced-access members) and roughly 2.5% fees following its February 2026 restructuring.

Hiive serves a higher-minimum segment — about $25,000 generally, rising to $100,000-plus for high-demand names like OpenAI or Anthropic — and its June 1, 2026 Form CRS discloses commissions up to 4.85% for buyers and 5.75% for sellers on direct transfers, though its managed funds charge 0% management fee and 0% carry. Company-run tender offers are the fourth route: OpenAI completed a $7 billion buyback of employee and early-shareholder shares on August 10, 2026 at the $852 billion price, following a $6.6 billion tender at $500 billion in October 2025 and a smaller $1.5 billion tender in 2024.

The fifth and sixth routes don't require accreditation at all. Robinhood Ventures Fund I (RVI), a publicly traded closed-end fund, discloses a roughly $75 million OpenAI position that any retail brokerage account can buy shares of — though RVI itself frequently trades at a premium to its net asset value, so you're paying for packaging, not just the underlying stake. And SPV-of-SPV structures on platforms like AngelList occasionally surface OpenAI exposure bundled with other late-stage AI names, though allocation and pricing there are the least transparent of the six.

Figures are August 2026 platform disclosures from Forge Global, EquityZen, Hiive's June 2026 Form CRS, and RVI's public fund filings. Fee structures change frequently on private-market platforms — verify current terms directly with each platform before investing.

Why OpenAI Keeps Running Tender Offers Instead of IPOing

Tender offers solve a real problem without the disclosure burden of a public listing: they let employees and early investors convert paper wealth to cash while OpenAI keeps its financials private. The pattern is now three tenders in roughly two years — $1.5 billion in 2024, $6.6 billion in October 2025 at a $500 billion valuation, and $7 billion in August 2026 at $852 billion — each timed to relieve liquidity pressure on staff without forcing a Wall Street debut.

The August 2026 tender is also a signal about IPO timing, not just a compensation mechanic. A company confident in a near-term listing has less reason to run a third employee buyback; running one instead suggests OpenAI is comfortable letting 2027 be the real target, consistent with Reuters' late-June 2026 reporting that the company is leaning that direction rather than the earlier "late 2026" speculation.

What the Headline Misses

The "$852 billion, most valuable AI startup" framing skips two inconvenient facts. First, Anthropic's own funding round pushed its valuation to $965 billion in the same window, meaning OpenAI is not currently the single most valuable private AI company by that metric — a reversal that happened within months of OpenAI's own valuation jump and gets little attention next to the bigger, rounder $852 billion number. Second, the Forge secondary price of $721.85 a share sits meaningfully below what the $852 billion round would imply per share on a like-for-like basis, which means some existing holders are choosing to sell at a discount to the "official" valuation rather than wait — a detail that headline coverage of the round size tends to leave out entirely.

There's also a structural point worth flagging: Microsoft's 27% stake, confirmed in the October 2025 for-profit restructuring, means OpenAI Group PBC isn't purely founder- and VC-controlled the way most pre-IPO AI startups are. Any retail-facing "buy OpenAI" product — RVI included — is effectively also a bet on how that Microsoft relationship evolves through 2032, when the current model-access agreement expires.

Who Should Actually Buy OpenAI Stock Exposure Now

For accredited investors with a $25,000-plus check size and patience for a multi-year illiquid hold, Hiive or Forge direct secondary purchases offer the closest thing to "real" OpenAI shares, complete with the transfer-restriction risk that comes with them. For smaller accredited checks, EquityZen's $5,000 minimum and SPV structure trade some transparency for accessibility. For anyone who isn't accredited, RVI is the only route that doesn't require jumping that threshold, but the NAV premium retail investors typically pay for that convenience should be weighed against simply waiting for a public listing that, per current reporting, is more likely in 2027 than 2026.

None of these routes are a substitute for reading OpenAI's eventual S-1 in full once it becomes public. Every number in this piece — the $20 billion-plus 2025 ARR, the $2 billion monthly run rate, the $852 billion valuation — comes from company disclosures, tender-offer reporting, and secondary-market quotes rather than audited public financials, and that gap is exactly what a real IPO closes.

How OpenAI's $852B Stacks Up Against Anthropic and SpaceX

Context matters for anyone sizing a pre-IPO position. OpenAI's $852 billion valuation no longer leads the private AI market — Anthropic's own funding round pushed it to $965 billion in the same stretch of 2026, roughly $113 billion higher, and SpaceX sits well ahead of both at approximately $1.45 trillion following its own recent secondary pricing. That ranking shift happened fast: OpenAI led the field as recently as March 2025 at $300 billion, and the gap to Anthropic has now inverted twice in under 18 months.

For a retail-facing vehicle like RVI, that peer-comparison matters more than it sounds — funds that market themselves on "access to the biggest private AI companies" are implicitly reweighting toward whichever of OpenAI, Anthropic, or SpaceX is leading in a given quarter, and the underlying NAV can swing on relative repricing between the three even if none of them individually changes its own valuation. Track how OpenAI's private pricing moves relative to its peers on our tech IPO tracker, which follows all three toward an eventual public listing.